Cardioxyl Raising Series A

Cardioxyl Pharmaceuticals Inc., a Towson, Md.-based drug startup focused on cardiovascular disease, has secured $3.2 million of a $14.5 million Series A round, according to a regulatory filing. Backers include Aurora Ventures and New Enterprise Associates. www.cardioxyl.com